indapamide has been researched along with Disease Models, Animal in 10 studies
Indapamide: A benzamide-sulfonamide-indole derived DIURETIC that functions by inhibiting SODIUM CHLORIDE SYMPORTERS.
indapamide : A sulfonamide formed by condensation of the carboxylic group of 4-chloro-3-sulfamoylbenzoic acid with the amino group of 2-methyl-2,3-dihydro-1H-indol-1-amine.
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In patients with arterial hypertension and left ventricular hypertrophy, perindopril + indapamide reduced blood pressure and left ventricular mass index and improved resting and hyperaemic myocardial blood flow." | 9.15 | Perindopril and indapamide reverse coronary microvascular remodelling and improve flow in arterial hypertension. ( Camici, PG; D'amati, G; Donato, L; Fommei, E; Ghione, S; Lombardi, M; Mancini, M; Neglia, D; Parker, H; Pisani, P; Varela-Carver, A, 2011) |
| "The fixed low-dose combination of the ACE inhibitor perindopril and the non-thiazide diuretic indapamide has been evaluated in the management of patients with mild to moderate hypertension." | 8.81 | Perindopril/indapamide 2/0.625 mg/day: a review of its place in the management of hypertension. ( Cheer, SM; Goa, KL; Matheson, AJ, 2001) |
| "In patients with arterial hypertension and left ventricular hypertrophy, perindopril + indapamide reduced blood pressure and left ventricular mass index and improved resting and hyperaemic myocardial blood flow." | 5.15 | Perindopril and indapamide reverse coronary microvascular remodelling and improve flow in arterial hypertension. ( Camici, PG; D'amati, G; Donato, L; Fommei, E; Ghione, S; Lombardi, M; Mancini, M; Neglia, D; Parker, H; Pisani, P; Varela-Carver, A, 2011) |
| "The fixed low-dose combination of the ACE inhibitor perindopril and the non-thiazide diuretic indapamide has been evaluated in the management of patients with mild to moderate hypertension." | 4.81 | Perindopril/indapamide 2/0.625 mg/day: a review of its place in the management of hypertension. ( Cheer, SM; Goa, KL; Matheson, AJ, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM | 1 |
| Yasgar, A | 1 |
| Teramoto, T | 1 |
| Lee, MH | 1 |
| Dorjsuren, D | 1 |
| Eastman, RT | 1 |
| Malik, N | 1 |
| Zakharov, AV | 1 |
| Li, W | 1 |
| Bachani, M | 1 |
| Brimacombe, K | 1 |
| Steiner, JP | 1 |
| Hall, MD | 1 |
| Balasubramanian, A | 1 |
| Jadhav, A | 1 |
| Padmanabhan, R | 1 |
| Simeonov, A | 1 |
| Nath, A | 1 |
| Brown, D | 1 |
| Moezzi, D | 1 |
| Dong, Y | 1 |
| Koch, M | 1 |
| Yong, VW | 1 |
| Simko, F | 1 |
| Pechanova, O | 2 |
| Neglia, D | 1 |
| Fommei, E | 1 |
| Varela-Carver, A | 1 |
| Mancini, M | 1 |
| Ghione, S | 1 |
| Lombardi, M | 1 |
| Pisani, P | 1 |
| Parker, H | 1 |
| D'amati, G | 1 |
| Donato, L | 1 |
| Camici, PG | 1 |
| Sládková, M | 1 |
| Kojsová, S | 1 |
| Jendeková, L | 1 |
| Lebrillant, E | 1 |
| Roulet, MJ | 1 |
| Robert, R | 1 |
| Schiavi, P | 1 |
| Guez, D | 1 |
| Jean, T | 1 |
| Del Rio, M | 1 |
| Chulia, T | 1 |
| Merchan-Perez, A | 1 |
| Remezal, M | 1 |
| Valor, S | 1 |
| Gonzalez, J | 1 |
| Gutierrez, JA | 1 |
| Contreras, JA | 1 |
| Lasuncion, MA | 1 |
| Tejerina, T | 1 |
| Matheson, AJ | 1 |
| Cheer, SM | 1 |
| Goa, KL | 1 |
| Boucher, FR | 1 |
| Schatz, CJ | 1 |
| Guez, DM | 1 |
| de Leiris, JG | 1 |
| Delbarre, B | 1 |
| Delbarre, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Open-label, Single-center, Single-arm Futility Trial Evaluating Oral Hydroxychloroquine 200mg BID for Reducing Progression of Disability in Patients With Primary Progressive Multiple Sclerosis (PPMS)[NCT02913157] | Phase 2 | 35 participants (Actual) | Interventional | 2016-11-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for indapamide and Disease Models, Animal
| Article | Year |
|---|---|
Perindopril/indapamide 2/0.625 mg/day: a review of its place in the management of hypertension.
Topics: Adult; Age Factors; Aged; Animals; Antihypertensive Agents; Blood Pressure; Disease Models, Animal; | 2001 |
1 trial available for indapamide and Disease Models, Animal
| Article | Year |
|---|---|
Perindopril and indapamide reverse coronary microvascular remodelling and improve flow in arterial hypertension.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Arterioles; Blood | 2011 |
8 other studies available for indapamide and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr | 2020 |
Combination of Hydroxychloroquine and Indapamide Attenuates Neurodegeneration in Models Relevant to Multiple Sclerosis.
Topics: Animals; Brain; Cells, Cultured; Disease Models, Animal; Drug Therapy, Combination; Female; Humans; | 2021 |
Recent trends in hypertension treatment: perspectives from animal studies.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Disease Models, Animal; Female; Hu | 2009 |
Chronic and acute effects of different antihypertensive drugs on femoral artery relaxation of L-NAME hypertensive rats.
Topics: Acetylcholine; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pre | 2007 |
Study of antiatherogenic properties of indapamide in a pharmacologic model.
Topics: Animals; Arteriosclerosis; Basement Membrane; Body Weight; Carotid Arteries; Cell Division; Choleste | 1993 |
Effects of indapamide on atherosclerosis development in cholesterol-fed rabbits.
Topics: Administration, Oral; Animals; Antihypertensive Agents; Aorta; Arteriosclerosis; Blood Pressure; Bod | 1995 |
Beneficial effect of indapamide in experimental myocardial ischemia.
Topics: Animals; Coronary Disease; Disease Models, Animal; Electron Spin Resonance Spectroscopy; Glutathione | 1992 |
Effect of indapamide on an experimental model of cerebral ischemia in hypertensive rats.
Topics: Animals; Brain Ischemia; Disease Models, Animal; Diuretics; Dose-Response Relationship, Drug; Drug E | 1988 |